צפלור 250 ישראל - עברית - Ministry of Health

צפלור 250

vitamed ltd,binyamina - cefaclor 250 mg / 5 ml - powder for suspension - cefaclor - treatment of infections caused by microorganisms susceptible to cefaclor e.g. respiratory tract infections, otitis media, skin and uti

HemaClear / S-MART ישראל - עברית - Ministry of Health

hemaclear / s-mart

"ohk medical devices ltd. / עונג הכרמל בע""מ" - אחות

CRADLE CAP CLEANSER ישראל - עברית - Ministry of Health

cradle cap cleanser

naveh pharma ltd. - כלל האוכלוסיה - לשימוש חיצוני על עור הקרקפת.

vaginal cleanser+lubricants ישראל - עברית - Ministry of Health

vaginal cleanser+lubricants

arome life ltd. - כלל האוכלוסיה - פתילות לניקוי הנרתיק+לובריקנטים

ספטל סקרב ישראל - עברית - Ministry of Health

ספטל סקרב

teva medical ltd - chlorhexidine gluconate - תמיסה - חיצוני - chlorhexidine gluconate 4 %w/v - chlorhexidine - chlorhexidine - surgical scrub: hand wash for health-care personnel pre-operative skin disinfection for patients undergoing elective surgery antimicrobial cleanser for minor skin wounds.

פולידין תרחיץ ישראל - עברית - Ministry of Health

פולידין תרחיץ

fischer pharmaceuticals ltd - povidone-iodine - תמיסה - חיצוני - povidone-iodine 7.5 %w/v - povidone-iodine - povidone-iodine - wound disinfection to prevent skin infections caused by bacteria and fungi, disinfection of infected skin conditions and sidinfection of the hands before medical procedures.

טייקרב ישראל - עברית - Ministry of Health

טייקרב

novartis israel ltd - lapatinib as ditosylate monohydrate - טבליות מצופות פילם - lapatinib as ditosylate monohydrate 250 mg - protein kinase inhibitors - tykerb is indicated for the treatment of adult patients with breast cancer, whose tumours overexpress her2 (erbb2);• in combination with capecitabine for patients with advanced or metastatic disease with progression following prior therapy, which must have included anthracyclines and taxanes and therapy with trastuzumab in the metastatic setting (see section 5.1).• tykerb is indicated in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overexpresses the her2 receptor for whom hormonal therapy is indicated. tykerb in combination with an aromatase inhibitor has not been compared to a trastuzumab-containing chemotherapy regimen for the treatment of metastatic breast cancer.